J2X-MC-PYAH - ClinicalTrials.gov - NCT04634409
J2X-MC-PYAH - ClinicalTrials.gov - NCT04634409
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have mild to moderate COVID-19 illness: Fever, cough, sore throat, not feeling well, headache, muscle pain, digestive symptoms, shortness of breath when active
Participants must test positive for COVID-19 within three days before starting the study
Participants must NOT
Participants must not be in the hospital
Participants must not be very overweight
Participants must not need a machine to help them breathe (ventilator)
Participants must not have a serious medical condition or infection other than COVID-19
Participants must not have received SARS-CoV-2 vaccine or plasma from a patient who has recovered from COVID-19 (convalescent plasma)
Participants must not be pregnant or breastfeeding
Trial Summary
Conditions the trial is for
COVID-19 (Coronavirus)
What the trial is testing?
LY3819253, Bamlanivimab, LY3832479, LY-CoV016, LY-CoV555
Could I receive a Placebo?
yes
Enrollment Goal
700
Trial Dates
October 2020 - March 2021
Trial Phase
2
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have mild to moderate COVID-19 illness: Fever, cough, sore throat, not feeling well, headache, muscle pain, digestive symptoms, shortness of breath when active
Participants must test positive for COVID-19 within three days before starting the study
Participants must NOT
Participants must not be in the hospital
Participants must not be very overweight
Participants must not need a machine to help them breathe (ventilator)
Participants must not have a serious medical condition or infection other than COVID-19
Participants must not have received SARS-CoV-2 vaccine or plasma from a patient who has recovered from COVID-19 (convalescent plasma)
Participants must not be pregnant or breastfeeding
Trial Summary
Conditions the trial is for
COVID-19 (Coronavirus)
What the trial is testing?
LY3819253, Bamlanivimab, LY3832479, LY-CoV016, LY-CoV555
Could I receive a Placebo?
yes
Enrollment Goal
700
Trial Dates
October 2020 - March 2021
Trial Phase
2
Trial Locations
Hide locations not currently recruiting